Rasha Aboelhassan: Proud to be the modulator for urogenital cancer debates in 4th Onco Egypt conference
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn:
“I’m proud to be the modulator for urogenital cancer debates in 4th Onco Egypt conference.
In this debate, I focused on early stages and first-line treatment of Advanced stage.
The debate includes experts from all cancer treatment organisation all over Egypt, including university hospitals as well as MOH hospitals.”
More posts featuring Rasha Aboelhassan.
Rasha Aboelhassan is a Senior Oncology Consultant at Nasser Institute Hospital. In addition to her clinical role, she volunteers as a reviewer for the World Journal of Surgical Oncology, contributing to advancements in the field and is in the Editorial Staff of Egyptian Journal of Human Genetics. Rasha has been accepted as a member of staging and Prognostic Factors Group of lung cancer SPFG.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023